Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
21 March 2017
Gavi 'effective and fit for purpose'
1 December 2016
Gavi gets top rating in UK Aid Review
Gavi welcomes Italy contribution
18 November 2016
Malaria vaccine pilots to go ahead
10 November 2016
Strong commitment needed to strengthen measles immunisation
8 November 2016
Statement on Gavi support to Yemen
2 November 2016
New Lancet figures show vaccine could save 600,000 women's lives from cervical cancer
13 October 2016
Gavi provides support for emergency cholera vaccine campaign in Haiti
5 October 2016
Gavi welcomes contribution of US$ 25 million from the Kingdom of Saudi Arabia
30 June 2016
Gavi Board reappoints WHO's Flavia Bustreo as vice-chair
26 May 2016
Gavi welcomes contribution of US$ 76 million from Government of Japan
Gavi welcomes price trend for pentavalent vaccine